Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Genetically determined polymorphisms in drug oxidation.

× No keyword cloud information.

20 in total

1. The relationship between debrisoquine oxidation phenotype and the pharmacokinetics of chlorpropamide.

Authors: J Kallio; R Huupponen; K Pyykkö
Journal: Eur J Clin Pharmacol Date: 1990 Impact factor: 2.953

Review 2. Ethnic differences in drug disposition and responsiveness.

Authors: A J Wood; H H Zhou
Journal: Clin Pharmacokinet Date: 1991-05 Impact factor: 6.447

3. Erythromycin breath test as an assay of glucocorticoid-inducible liver cytochromes P-450. Studies in rats and patients.

Authors: P B Watkins; S A Murray; L G Winkelman; D M Heuman; S A Wrighton; P S Guzelian
Journal: J Clin Invest Date: 1989-02 Impact factor: 14.808

4. Effect of liver disease on dextromethorphan oxidation capacity and phenotype: a study in 107 patients.

Authors: D Larrey; G Babany; M Tinel; E Freneaux; G Amouyal; F Habersetzer; P Letteron; D Pessayre
Journal: Br J Clin Pharmacol Date: 1989-09 Impact factor: 4.335

5. Genetically-determined interaction between propafenone and low dose quinidine: role of active metabolites in modulating net drug effect.

Authors: C Funck-Brentano; H K Kroemer; H Pavlou; R L Woosley; D M Roden
Journal: Br J Clin Pharmacol Date: 1989-04 Impact factor: 4.335

10. Clinical significance of the trimethadione tolerance test in chronic hepatitis: a useful indicator of hepatic drug metabolizing capacity.

Authors: M Abei; E Tanaka; N Tanaka; Y Matsuzaki; T Ikegami; A Ishikawa; T Osuga
Journal: J Gastroenterol Date: 1995-08 Impact factor: 7.527

Genetically determined polymorphisms in drug oxidation.

1. The relationship between debrisoquine oxidation phenotype and the pharmacokinetics of chlorpropamide.

Review 2. Ethnic differences in drug disposition and responsiveness.

3. Erythromycin breath test as an assay of glucocorticoid-inducible liver cytochromes P-450. Studies in rats and patients.

4. Effect of liver disease on dextromethorphan oxidation capacity and phenotype: a study in 107 patients.

5. Genetically-determined interaction between propafenone and low dose quinidine: role of active metabolites in modulating net drug effect.

6. Prevalence of drug hydroxylator phenotypes in Belgium.

Review 7. [The development of pharmacogenetics--a retrospective on the 75th birthday of Hans Herken].

8. Debrisoquine oxidation phenotype during neuroleptic monotherapy.

9. Debrisoquine oxidation in a Finnish population: the effect of oral contraceptives on the metabolic ratio.

10. Clinical significance of the trimethadione tolerance test in chronic hepatitis: a useful indicator of hepatic drug metabolizing capacity.